Abstract: A dynamic lumbar realignment system is provided. A stabilizing and compressive strap is configured to be positioned onto a body garment with a pelvic cover, a waistband, a left thigh short sleeve and a right thigh short sleeve or is configured to be positioned onto a user with a pelvis, a waist, a left thigh and a right thigh along a therapeutic orientation path. The stabilizing and compressive strap comprises a first strap end and a second strap end. The therapeutic orientation path comprises a beginning and an end. The first strap end is fixed at the beginning while the second strap end is fixed at the end. The stabilizing and compressive strap is arranged along the therapeutic orientation path in such a way that abdominal compression, pelvic tilt and thigh rotation are dynamically integrated so as to provide and generate a therapeutic effect.

Abstract: Provided herein is the use of an ECHO-7 class oncolytic virus for the treatment of uveal melanoma and compositions comprising the ECHO-7 virus and pharmaceutically acceptable carrier for the treatment of uveal melanoma.

Abstract: An adjustable rearview mirror that is designed to quickly transition between transparent and reflective states. The apparatus is configured to resemble traditional rearview mirrors used in vehicles. The apparatus includes a window mount, a pivoting connection arm, and a user controlled mirror panel. The window mount connects the rearview mirror to the windshield of a vehicle. The pivoting connection arm enables a user to reposition the rearview mirror at will. The user controlled panel can be placed into a reflective or a transparent state based on user input. A user is able to gain a relatively unhindered view of traffic through a vehicle windshield.

Abstract: An adjustable rearview mirror that is designed to quickly transition between transparent and reflective states. The apparatus is configured to resemble traditional rearview mirrors used in vehicles. The apparatus includes a window mount, a pivoting connection arm, and a user controlled mirror panel. The window mount connects the rearview mirror to the windshield of a vehicle. The pivoting connection arm enables a user to reposition the rearview mirror at will. The user controlled panel can be placed into a reflective or a transparent state based on user input. A user is able to gain a relatively unhindered view of traffic through a vehicle windshield.

Abstract: An adjustable rearview mirror that is designed to quickly transition between transparent and reflective states. The apparatus is configured to resemble traditional rearview mirrors used in vehicles. The apparatus includes a window mount, a pivoting connection arm, and a user controlled mirror panel. The window mount connects the rearview mirror to the windshield of a vehicle. The pivoting connection arm enables a user to reposition the rearview mirror at will. The user controlled panel can be placed into a reflective or a transparent state based on user input. A user is able to gain a relatively unhindered view of traffic through a vehicle windshield.

Abstract: An adjustable rearview mirror that is designed to quickly transition between transparent and reflective states. The apparatus is configured to resemble traditional rearview mirrors used in vehicles. The apparatus includes a window mount, a pivoting connection arm, and a user controlled mirror panel. The window mount connects the rearview mirror to the windshield of a vehicle. The pivoting connection arm enables a user to reposition the rearview mirror at will. The user controlled panel can be placed into a reflective or a transparent state based on user input. A user is able to gain a relatively unhindered view of traffic through a vehicle windshield.

Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.

Abstract: A dynamic lumbar realignment system includes a compressive lower body garment that provides abdominal compression and a stabilizing strap that induces thigh rotation in order to produce a therapeutic effect. Pelvic tilt provided by the compressive lower body garment and thigh rotation provided by the stabilizing strap assist the user in maintaining proper posture. The stabilizing strap is arranged and oriented on the compressive lower body garment in a therapeutic orientation path that enables the stabilizing strap to exert a desired therapeutic effect on the user. The therapeutic orientation path is defined by a combination of a plurality of strap-supporting attachment points and a plurality of strap-guiding attachment points on the compressive lower body garment. Numerous variants of the dynamic lumbar realignment system are available to address various issues such as lumbar hyperlordosis and lumbar hypolordosis.

Abstract: The present invention relates to prodrugs of compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The prodrugs of the compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to prodrugs of compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The prodrugs of the compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.

Abstract: The present invention relates to prodrugs of compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The prodrugs of the compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.

Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to prodrugs of compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The prodrugs of the compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.

Abstract: The present invention relates to prodrugs of compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The prodrugs of the compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.